Publicaciones en colaboración con investigadoras/es de Universidad de Cantabria (30)

2023

  1. Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  2. Inhibition of Prolyl Oligopeptidase Restores Prohibitin 2 Levels in Psychosis Models: Relationship to Cognitive Deficits in Schizophrenia

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

2019

  1. Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

    Translational Psychiatry, Vol. 9, Núm. 1

2018

  1. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders

    Biochemical Pharmacology, Vol. 157, pp. 258-265

  2. The endocannabinoid system in mental disorders: Evidence from human brain studies

    Biochemical Pharmacology, Vol. 157, pp. 97-107

2017

  1. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain

    Neuropharmacology, Vol. 114, pp. 114

2015

  1. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects

    Addiction Biology, Vol. 20, Núm. 4, pp. 773-783

2014

  1. Galanin activated Gi/o-proteins in human and rat central nervous systems

    Neuropeptides, Vol. 48, Núm. 5, pp. 295-304

2012

  1. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

    Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319

2010

  1. α2-adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims

    Biological Psychiatry, Vol. 68, Núm. 9, pp. 869-872

2009

  1. Functional autoradiography and gene expression analysis applied to the characterization of the α2-adrenergic system in the chicken brain

    Journal of Chemical Neuroanatomy, Vol. 38, Núm. 4, pp. 282-291

2008

  1. COMPARISON OF GENE EXPRESSION PATTERNS IN CEREBRAL CORTEX BETWEEN THREE DIFFERENT ANIMAL MODELS OF DEPRESSION

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

  2. Gene expression patterns in brain cortex of three different animal models of depression

    Genes, Brain and Behavior, Vol. 7, Núm. 6, pp. 649-658

  3. Muscarinic receptor changes in the gerbil thalamus during aging

    Brain Research, Vol. 1243, pp. 38-46

2006

  1. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer's disease

    Amino Acids, Vol. 31, Núm. 4, pp. 449-456

  2. Cannabinoid system in the budgerigar brain

    Brain Research, Vol. 1087, Núm. 1, pp. 105-113

  3. Transmembrane signaling through phospholipase C-β in the developing human prefrontal cortex

    Journal of Neuroscience Research, Vol. 84, Núm. 1, pp. 13-26

2005

  1. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties

    Psychopharmacology, Vol. 182, Núm. 3, pp. 400-413

2002

  1. Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis

    Synapse, Vol. 45, Núm. 4, pp. 245-249

2001

  1. Reduced phospholipase C-β activity and isoform expression in the cerebellum of Ts65Dn mouse: A model of down syndrome

    Journal of Neuroscience Research, Vol. 66, Núm. 4, pp. 540-550